| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |